SynthesisRenal failure2026

Comparative efficacy and safety of apixaban and rivaroxaban versus warfarin in atrial fibrillation patients with end-stage renal disease: a systematic review and meta-analysis.

Xiaoyuan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.